Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

A structure-activity relationship study of platelet-activating factor

Technical Report ·
OSTI ID:6838850
Several analogues of platelet-activating factor (1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine, PAF), an alkylglycerophospholipid that was found to be a mediator in Type I immediate hypersensitivity and also possessed potent hypotensive properties, were synthesized. These PAF analogues were evaluated in a qualitative structure-activity relationship study for their rabbit neutrophil degranulation properties and their antihypertensive properties in rats. Variations were made in each of the moieties attached to the three glycerol backbone carbons. Variation in sn-1-0-alkyl chain length from fourteen to nineteen carbons and introduction of one or two double bonds revealed that the 1-0-hexadecyl species of PAF was the most active analogue in this series in our assay systems. Substitution of various deoxyalkyl groups for the 2-0-acetyl moiety resulted in severely diminished bioactivities and no inhibition of rat plasma acetylhydrolase activity. Substitution of bulky trialkylammonium moieties for the trimethylammonium portion of the phosphocholine moiety resulted in an analogue (triethylammonium, 41) with reduced immediate hypersensitivity properties and 560% relative antihypertensive potency.
Research Organization:
North Carolina Univ., Chapel Hill (USA)
DOE Contract Number:
AC05-76OR00033
OSTI ID:
6838850
Report Number(s):
DOE/OR/00033-T413; ON: DE88015646
Country of Publication:
United States
Language:
English